NCT06831175 2025-06-03Phase II Study of PD-1 Inhibitor Combined With Apatinib and Mitotane in the Treatment of Advanced Adrenal Cortical CarcinomaWest China HospitalPhase 2 Recruiting28 enrolled
NCT04318730 2024-07-17Phase II Study for Combination of Camrelizumab and Apatinib in the Second-line Treatment of Recurrent or Metastatic Adrenocortical CarcinomaWest China HospitalPhase 2 Recruiting21 enrolled